Moreover, lnc-PKD2-2-3 was observed to have been dramatically upregulated in CCA stem-like cells, which illustrated that lnc-PKD2-2-3 might act as a fresh CSC marker (Qiu et al., 2019). This evidence concerns the gene PKD2 and cholangiocarcinoma.